Literature DB >> 30467121

LRRK2 and Rab GTPases.

Suzanne R Pfeffer1.   

Abstract

Leucine-rich repeat kinase 2 (LRRK2) is mutated in familial Parkinson's disease, and pathogenic mutations activate the kinase activity. A tour de force screen by Mann and Alessi and co-workers identified a subset of Rab GTPases as bona fide LRRK2 substrates. Rab GTPases are master regulators of membrane trafficking and this short review will summarize what we know about the connection between LRRK2 and this family of regulatory proteins. While, in most cases, Rab GTPase phosphorylation is predicted to interfere with Rab protein function, the discovery of proteins that show preferential binding to phosphorylated Rabs suggests that more complex interactions may also contribute to mutant LRRK2-mediated pathology.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  LRRK2; Parkinson's disease; Rab GTPase; kinase; primary cilia

Mesh:

Substances:

Year:  2018        PMID: 30467121     DOI: 10.1042/BST20180470

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  13 in total

1.  The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.

Authors:  Briana R De Miranda; Sandra L Castro; Emily M Rocha; Christopher R Bodle; Katrina E Johnson; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2021-02-23       Impact factor: 5.996

Review 2.  Parkinson's disease and mitophagy: an emerging role for LRRK2.

Authors:  Francois Singh; Ian G Ganley
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

3.  Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction.

Authors:  Ayan Hussein; Christopher A Guevara; Pamela Del Valle; Swati Gupta; Deanna L Benson; George W Huntley
Journal:  Neuroscientist       Date:  2021-05-08       Impact factor: 7.235

Review 4.  Rab7a and Mitophagosome Formation.

Authors:  Esther Hui Na Tan; Bor Luen Tang
Journal:  Cells       Date:  2019-03-08       Impact factor: 6.600

Review 5.  Phosphoregulation on mitochondria: Integration of cell and organelle responses.

Authors:  Maribel Lucero; Ana E Suarez; Jeremy W Chambers
Journal:  CNS Neurosci Ther       Date:  2019-04-25       Impact factor: 5.243

Review 6.  The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases.

Authors:  Liang Qu; Chao Pan; Shi-Ming He; Bing Lang; Guo-Dong Gao; Xue-Lian Wang; Yuan Wang
Journal:  Front Mol Neurosci       Date:  2019-05-21       Impact factor: 5.639

7.  LRRK2 in Infection: Friend or Foe?

Authors:  Susanne Herbst; Maximiliano G Gutierrez
Journal:  ACS Infect Dis       Date:  2019-04-05       Impact factor: 5.084

8.  PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins.

Authors:  Kerryn Berndsen; Pawel Lis; Wondwossen M Yeshaw; Paulina S Wawro; Raja S Nirujogi; Melanie Wightman; Thomas Macartney; Mark Dorward; Axel Knebel; Francesca Tonelli; Suzanne R Pfeffer; Dario R Alessi
Journal:  Elife       Date:  2019-10-30       Impact factor: 8.140

Review 9.  LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same.

Authors:  Daniel C Berwick; George R Heaton; Sonia Azeggagh; Kirsten Harvey
Journal:  Mol Neurodegener       Date:  2019-12-21       Impact factor: 14.195

10.  Pharmacological rescue of impaired mitophagy in Parkinson's disease-related LRRK2 G2019S knock-in mice.

Authors:  Francois Singh; Alan R Prescott; Philippa Rosewell; Graeme Ball; Alastair D Reith; Ian G Ganley
Journal:  Elife       Date:  2021-08-03       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.